TP53 and central nervous system cancer: In Grade 3 and Grade 4 gliomas, regardless of IDH status, TERTp mutation displayed mutual exclusivity with ATRX, TP53, IDH1, and MYC alterations, while co‐occurring with EGFR and MET alterations.